Croda International (LON:CRDA – Get Free Report) had its price objective raised by Deutsche Bank from GBX 3,300 to GBX 4,100 in a research note issued on Monday, London Stock Exchange reports. The brokerage currently has a “buy” rating on the stock. Deutsche Bank‘s price target would suggest a potential upside of 7.05% from the stock’s current price.
A number of other research analysts have also recently commented on the company. Jefferies Financial Group reaffirmed a “buy” rating and set a GBX 4,000 target price on shares of Croda International in a research note on Thursday, November 5th. Citigroup boosted their price target on shares of Croda International from GBX 3,050 to GBX 3,200 and gave the company a “neutral” rating in a report on Wednesday, July 29th. Finally, Berenberg Bank upped their price objective on Croda International from GBX 3,600 to GBX 4,400 and gave the stock a “buy” rating in a research note on Friday, November 6th. Four equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of GBX 3,810.
View Our Latest Report on CRDA
Croda International Trading Up 1.6%
Shares of LON CRDA traded up GBX 62 during trading hours on Monday, hitting GBX 3,830. 830,404 shares of the company traded hands, compared to its average volume of 5,366,195. The company has a current ratio of 2.57, a quick ratio of 2.25 and a debt-to-equity ratio of 36.06. Croda International has a 12 month low of GBX 2,488 and a 12 month high of GBX 3,856. The stock has a market capitalization of £5.34 billion, a price-to-earnings ratio of 67.31, a price-to-earnings-growth ratio of 1.40 and a beta of 0.92. The company’s 50 day moving average price is GBX 3,442.43 and its 200 day moving average price is GBX 3,101.13.
About Croda International
Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world. Sustainability is a core part of the Groups strategy with a commitment to be Climate, Land and People positive by 2030.
See Also
- Five stocks we like better than Croda International
- Could Big Buybacks Be the Next Catalyst for These 3 AI Stocks?
- 3 AI Hardware Leaders Are Raising Dividends, But Which Offers More Income?
- Sandisk’s Sell-Off May Be Losing Steam, But the Biggest Risk Still Looms
- Meta’s Access to Capital Remains Strong, But Borrowing Is Becoming More Expensive
Receive News & Ratings for Croda International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Croda International and related companies with MarketBeat.com's FREE daily email newsletter.
